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Summary
What is already known on this topic?
Hypertension and diabetes have major implications for perinatal maternal
morbidity and mortality. Women with chronic hypertension face substan-
tially increased risk of life-threatening maternal outcomes, and diabetes
during pregnancy increases the risk for unfavorable maternal and infant
outcomes.
What is added by this report?
This analysis improves our understanding of the prevalence of hyperten-
sion and diabetes among women of reproductive age and may facilitate
opportunities to improve awareness and control of these conditions, im-
prove disparities in women’s health, and improve birth outcomes.
What are the implications for public health practice?
Adequately addressing these conditions provides an opportunity to reduce
disparities in women’s health and ultimately improve birth outcomes.
Abstract
Introduction
Diagnosis and control of chronic conditions have implications for
women’s health and are major contributing factors to maternal and
infant morbidity and mortality. This study estimated the preval-
ence of hypertension and diabetes in non-pregnant women of re-
productive age in the United States, the proportion who were un-
aware of their condition or whose condition was not controlled,
and differences in the prevalence of these conditions by selected
characteristics.
Methods
We used data from the 2011–2016 National Health and Nutrition
Examination Survey to estimate overall prevalence of hyperten-
sion and diabetes among women of reproductive age (aged 20–44
y), the proportion who were unaware of having hypertension or
diabetes, and the proportion whose diabetes or hypertension was
not controlled. We used logistic regression models to calculate ad-
justed prevalence ratios to assess differences by selected character-
istics.
Results
The  estimated  prevalence  of  hypertension  was  9.3%  overall.
Among those with hypertension, 16.9% were unaware of their hy-
pertension  status  and  40.7%  had  uncontrolled  hypertension.
Among women with diabetes, almost 30% had undiagnosed dia-
betes, and among those with diagnosed diabetes, the condition was
not controlled in 51.5%.
Conclusion
This analysis improves our understanding of the prevalence of hy-
pertension and diabetes among women of reproductive age and
may facilitate opportunities to improve awareness and control of
these conditions, reduce disparities in women’s health, and im-
prove birth outcomes.
Introduction
Hypertension is the leading risk factor for heart disease and stroke,
the first and fourth major causes of death in the United States, re-
spectively (1). Hypertension is a major contributing factor to ma-
ternal and fetal morbidity, complicating up to 5% of the estimated
4 million pregnancies in the United States annually (2). Hyperten-
sion at a young age increases the risk of heart disease over the life-
time (3–5). Women with chronic hypertension and women with
pregnancy-related hypertension have an increased risk of life-
threatening maternal and infant outcomes, such as placental abrup-
tion, pulmonary edema, stroke, renal failure, preterm birth, in-
trauterine growth restriction, and death (2,6).
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Diabetes is another one of the most common chronic diseases in
the United States (7). Approximately 13% of adults (aged ≥20)
have diabetes; 9.6% have physician-diagnosed diabetes and 3.0%
have undiagnosed diabetes (4). For women of reproductive age,
detection and management of pre-existing diabetes can help avoid
the risks for poor maternal and infant outcomes (8). Among wo-
men with pre-existing diabetes, failure to properly control dia-
betes before conception and during the initial trimester of preg-
nancy increases risks for major birth defects and stillbirths. Fail-
ure to properly control diabetes during the last 2 trimesters can
lead to large-for-gestational-age babies, which could pose risks for
both mother and child.
Overall, the prevalence of chronic disease among women of repro-
ductive age in the United States has increased, and improving wo-
men’s health during their  reproductive years may improve the
health of future generations (9). The objective of this study was to
estimate the prevalence of hypertension and diabetes in non-preg-
nant women of reproductive age in the United States, the propor-
tion  of  these  women who were  unaware  of  their  condition  or
whose condition was not controlled, and differences in the preval-
ence of these conditions by selected characteristics.
Methods
This  study  used  questionnaire  and  examination  data  from the
2011–2016 National Health and Nutrition Examination Survey
(NHANES) for hypertension and diabetes. NHANES is a nation-
ally representative cross-sectional survey designed to assess the
health and nutritional status of the US civilian, noninstitutional-
ized population. The survey became continuous in 1999, and data
are released in 2-year cycles. Our study included data on non-
pregnant women of reproductive age (aged 20–44) who provided
an in-home medical history and underwent physical examination
and laboratory testing at a mobile examination center. All parti-
cipants undergo an in-home interview, during which NHANES
collects  self-reported data on demographic characteristics,  so-
cioeconomic characteristics, and health outcomes, including in-
formation about and medications for hypertension. A subset of
participants from the in-home interviews undergo physical exam-
inations at a mobile examination center, during which blood pres-
sure data are collected. A subset of participants from the physical
examination have laboratory testing, during which data on fasting
plasma glucose (FPG) and hemoglobin A1c (HbA1c) are collected.
Pregnancy status was self-reported during the in-home interview.
Those who reported that they were not pregnant or did not know
their pregnancy status were given a urine pregnancy test. If the ur-
ine test was negative, the participant was coded as not pregnant. If
the urine test  result  was positive, the participant was coded as
pregnant. We excluded from analysis women coded as pregnant.
The data were weighted to account for selection and nonresponse.
Of the 29,902 participants who completed the in-home interview,
3,613 were non-pregnant women of reproductive age (weighted
estimate, 50,018,292) and 192 were pregnant women of reproduct-
ive age. Of the 28,695 participants examined, 3,477 were non-
pregnant women of reproductive age and 192 were pregnant wo-
men  of  reproductive  age.  Of  the  3,477  non-pregnant  women,
blood pressure readings were missing for 173 participants and in-
formation on blood pressure medication was missing for 1 parti-
cipant; these participants were excluded from the analysis of hy-
pertension. The resulting sample size for estimating the preval-
ence of hypertension was 3,303 participants.
Of the 28,695 participants examined at the mobile examination
center, NHANES obtained 9,759 fasting blood samples from parti-
cipants aged 12 or older. Of these 9,759 participants, 8,512 had a
positive, nonzero fasting subsample weight. Of those 8,512 parti-
cipants, 1,462 were non-pregnant women of reproductive age and
65 were pregnant women of reproductive age. Of the 1,462 non-
pregnant women, 1 participant was excluded from analysis be-
cause she did not know if she was told she had diabetes. The res-
ulting sample size for estimating diabetes was 1,461 (weighted es-
timate, 50,406,331).
Covariates
Demographic information collected during the in-home interview
included age (categorized into 20–34, 35–39, or 40–44 y), self-
identified race/ethnicity (non-Hispanic white, non-Hispanic black,
Hispanic, or other), education level (<high school diploma, high
school diploma, or >high school diploma), and health insurance
(public, private, insurance, or uninsured). Body mass index (BMI)
was calculated by using data on height and weight collected dur-
ing physical examination (normal or underweight [BMI <25.0 kg/
m2]; overweight [BMI from 25.0 to <30.0 kg/m2]; obese [BMI
≥30.0 kg/m2]).
Hypertension
Hypertension was defined as having an average of up to 3 consec-
utive measurements of systolic blood pressure ≥140 mm Hg or
diastolic blood pressure ≥90 mm Hg, or when participants repor-
ted currently using medication to lower blood pressure (10,11).
Participants were asked during the in-home interview if they had
ever been told by a doctor or other health professional that they
had hypertension. Among participants who were identified as hav-
ing hypertension, those that were never told of their hypertension
status by a doctor or a health professional and were not taking pre-
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scribed blood pressure medicine were categorized as being un-
aware of their hypertension status. Uncontrolled hypertension was
defined as  systolic  blood pressure  ≥140 mm Hg and diastolic
blood pressure ≥90 mm Hg among those with hypertension (11).
Diabetes
In this study, we defined diabetes by using 2 laboratory values,
FPG and HbA1c, and a self-report of diagnosed diabetes. We re-
stricted the analytic  sample to women who provided a fasting
blood sample in the morning session of the mobile examination
and  had  fasted  for  8  to  23  hours.  FPG values  for  2011–2016
NHANES  were  calibrated  to  FPG  values  for  1999–2004
NHANES for comparability purposes; calibration was necessary
because NHANES changed its  methods for  measuring FPG in
2005–2006. We considered participants to have diagnosed dia-
betes if they self-reported that they were told by a doctor or other
health professional that they had diabetes. Participants were con-
sidered not to have diagnosed diabetes if they never received a
diagnosis and had an HbA1c ≥6.5% or an FPG ≥126 mg/dL. Un-
controlled diabetes was defined as having diagnosed diabetes and
an HbA1c ≥7% (12,13).
Statistical analysis
We performed all analyses with SAS-callable SUDAAN version
9.3 (SAS Institute Inc) using appropriate sample weights, stratific-
ation, and clustering to account for the complex survey design. We
calculated the distribution of participant characteristics and estim-
ated the prevalence of hypertension, lack of awareness of hyper-
tension status, uncontrolled hypertension, diabetes, undiagnosed
diabetes, and uncontrolled diabetes, and 95% confidence intervals
(CIs). Next, we estimated the prevalence of these conditions by
participant characteristics (age group, race/ethnicity, education
level, BMI, and insurance status). We used the χ2 test to assess ho-
mogeneity of distribution across each participant characteristic. Fi-
nally, we used PROC RLOGIST to calculate multivariable pre-
dicted marginal proportions from logistic regression models. We
adjusted the resulting prevalence ratios (PRs) for all other covari-
ates in the multivariable model. The covariates used in the models
included all participant characteristics. We did not use BMI as a
covariate in the model for uncontrolled diabetes because the value
was zero for the category normal or underweight. Significance
was determined by using a P value <.05.
Results
The overall prevalence of hypertension among women of repro-
ductive age was 9.3%; of these women, 16.9% were unaware of
their hypertension status and 40.7% had uncontrolled hyperten-
sion (Table 1). The proportion of women with hypertension who
reported using blood pressure medication was 70.0% (95% CI,
64.1%–75.4%). The prevalence of hypertension was higher among
women aged 40 to 44 (adjusted PR = 5.1; 95% CI, 3.7–7.1) and
women aged 35 to 39 (adjusted PR = 3.9; 95% CI, 3.0–5.2) than
among women aged 20 to 34 and higher  among non-Hispanic
black women (adjusted PR = 1.7; 95% CI, 1.4–2.2) than among
non-Hispanic  white  women.  Hypertension was  more  common
among obese women (adjusted PR = 3.8; 95% CI, 2.8–5.3) and
overweight women (adjusted PR = 1.7; 95% CI, 1.1–2.5) than
among normal-weight or underweight women (Table 2).
The prevalence of being unaware of hypertension status was lower
among women aged 40 to 44 (adjusted PR = 0.5; 95% CI, 0.2–0.9)
than among women aged 20 to 34, among obese women (adjusted
PR = 0.4; 95% CI, 0.2–0.8) and overweight women (adjusted PR
= 0.3;  95% CI,  0.1–0.6)  than among normal-weight  or  under-
weight women, and among publicly insured women (adjusted PR
= 0.5; 95% CI, 0.2–0.8) than among privately insured women (Ta-
ble 2). The prevalence of uncontrolled hypertension was lower
among women aged 40 to 44 (adjusted PR = 0.7; 95% CI, 0.5–0.9)
than among women aged 20 to 34 and higher among women of
“other” race/ethnicity (adjusted PR = 2.0; 95% CI, 1.3–3.0) and
non-Hispanic black women (adjusted PR = 1.7; 95% CI, 1.2–2.4)
than among non-Hispanic white women. The prevalence of uncon-
trolled hypertension was also lower among obese women (adjus-
ted PR = 0.6; 95% CI, 0.5–0.9) and overweight women (adjusted
PR = 0.4; 95% CI, 0.2–0.7) than among normal-weight or under-
weight women and was higher among uninsured women (adjusted
PR = 1.5; 95% CI, 1.1–2.1) than among privately insured women
(Table 2).
The overall prevalence of diabetes among non-pregnant women of
reproductive age was 4.5%; the prevalence of diagnosed diabetes
was 3.2%, and the prevalence of undiagnosed diabetes was 1.3%.
Thus,  approximately 30% of  women with diabetes  had undia-
gnosed diabetes. Among women with diagnosed diabetes, the pre-
valence of uncontrolled diabetes was 51.5% (Table 1). Diabetes
was more common among women aged 40 to 44 (adjusted PR =
3.1; 95% CI, 1.7–5.8) and women aged 35 to 39 (adjusted PR =
2.2; 95% CI, 1.2–4.1) than among women aged 20 to 34, among
women of  “other”  race/ethnicity  (adjusted  PR = 2.6;  95% CI,
1.1–6.0) and non-Hispanic black women (adjusted PR = 2.0; 95%
CI, 1.1–3.5) than among non-Hispanic white women, and among
obese women (adjusted PR = 13.5; 95% CI, 4.4–41.5) and over-
weight women (adjusted PR = 5.5; 95% CI, 1.6–18.8) than among
normal-weight or underweight women. Women of “other” race/
ethnicity (adjusted PR = 8.6; 95% CI, 2.1–35.2), non-Hispanic
black women (adjusted PR = 6.1; 95% CI, 2.0–18.6), and Hispan-
ic women (adjusted PR = 3.7; 95% CI, 1.2–11.1) had a higher pre-
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valence of undiagnosed diabetes than did non-Hispanic white wo-
men, as did obese women (adjusted PR = 7.2; 95% CI, 1.7–30.2)
compared with normal-weight or underweight women (Table 3).
Discussion
Our analysis used NHANES data to provide prevalence estimates
on 2 major chronic conditions relevant to preconception and over-
all health among women. In this representative sample of non-
pregnant  women of  reproductive age in the United States,  the
overall prevalence of hypertension was 9.3% and the overall pre-
valence of diabetes was 4.5%. Approximately 17% of women with
hypertension in our sample were unaware that they had it,  and
more than 40% had uncontrolled hypertension. We also found that
almost 30% of women with diabetes never received a diagnosis,
and among women with diagnosed diabetes, more than half had
uncontrolled diabetes.
The high proportion of undiagnosed diabetes may be due partially
to an absence of well-defined screening recommendations for dia-
betes among women of reproductive age. The US Preventive Ser-
vices Task Force and the American Diabetes Association recom-
mend screening adults aged 45 or older who are overweight or
obese (13,14). These guidelines mention that people with certain
risk factors (ie, family history of diabetes, history of gestational
diabetes or polycystic ovarian syndrome, or members of certain
racial/ethnic groups) may be at increased risk for diabetes at a
younger age. However, recommendations for screening among
younger patients with one or more risk factors for diabetes re-
mains at the discretion of health care providers (13). The Ameri-
can Diabetes Association also provides guidelines for testing chil-
dren and adolescents for prediabetes and type 2 diabetes: children
and adolescents aged 18 or younger who are overweight or obese
and have at least 1 additional risk factor should be considered
(14). However, no guidelines specify the age range (20–44 y) as-
sessed in our analysis.
In contrast to recommendations for diabetes, the US Preventive
Services Task Force recommends screening all adults (≥18 y) for
hypertension (13). Although the prevalence of hypertension in our
study was higher among women aged 40 to 44 (than among wo-
men aged 20 to 34) and among overweight or obese women (than
among normal-weight or underweight women), these women were
less likely to be unaware of their hypertension status or have un-
controlled hypertension. Older age and overweight/obesity are
well-established risk factors for hypertension and other chronic
conditions (15). Thus, older women and women with high BMIs
may have more health care encounters and more opportunities for
hypertension screening and therefore have better access to care for
hypertension management.
The prevalence of hypertension and diabetes increased with age
and BMI in our study sample, similar to increases among the gen-
eral population (13). Although we found no difference in the pre-
valence of hypertension by insurance status, publicly insured wo-
men were less likely than privately insured women age to be un-
aware of their  hypertension status and uninsured women were
more likely to have uncontrolled hypertension. Women who lack
health insurance may have less access to care and face more chal-
lenges in obtaining resources to manage chronic health conditions.
We also found that non-Hispanic black women were more likely
than non-Hispanic white women to have both hypertension and
uncontrolled hypertension and that diabetes prevalence was high-
er among non-Hispanic black women and women of “other” race/
ethnicity than among non-Hispanic white women. Among the 4
racial/ethnic groups studied, the prevalence of undiagnosed dia-
betes was lowest among non-Hispanic white women.
Our results demonstrated that a substantial proportion of women
of reproductive age with hypertension and diabetes do not have
these conditions under control (hypertension, 40.7% and diabetes,
51.5%). Although hypertension and diabetes are often considered
a public health problem among older adults, these conditions can
also have long-term consequences for younger adults. Adults who
maintain or decrease their blood pressure to normal levels by and
during middle age (41–55 y) have the lowest lifetime risk for car-
diovascular disease (ie, fatal coronary heart disease, hospitalized
myocardial infarction, nonhospitalized myocardial infarction, and
fatal and nonfatal stroke [16]), compared with adults who do not
maintain or decrease their blood pressure to normal levels.
Length of time living with diabetes is linearly associated with in-
creased risk of fatal coronary heart disease among women aged 30
to 55 (17). Any chronic hypertension, regardless of severity and
level of control, is associated with adverse maternal and fetal out-
comes (18), including pre-eclampsia and preterm birth. However,
women with uncontrolled blood pressure have a greater risk of ad-
verse maternal and fetal outcomes than women with controlled hy-
pertension at less than 20 weeks gestational age (19). Pre-existing
maternal diabetes (type 1 and type 2) is associated with an in-
creased risk of congenital malformations during pregnancy, and up
to the seventh gestational week, with HbA1c in the range of 6.3%
to 11% (45–97 mmol/mol); pre-existing maternal diabetes is the
most important predictor of congenital malformations (20). Pre-
existing diabetes is also associated with an increased risk of ad-
verse  outcomes,  including stillbirth,  macrosomia (birthweight
>4,000 g), caesarean section, and shoulder dystocia (21). Addi-
tionally, gestational diabetes increases the risk for future type 2
diabetes (22).
Ideally, diagnosing and achieving optimum control of chronic con-
ditions, including diabetes and hypertension, among women of re-
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productive age should be a part of preconception care (23). For
women who want to delay or avoid becoming pregnant, the 2016
US Medical Eligibility Criteria for Contraceptive Use has recom-
mendations on contraception for men and women with certain
medical conditions, including hypertension and diabetes (24). Ad-
ditionally, providers can screen for and treat complications as well
as modify medications for their potential teratogenic effects (20).
Health care providers and public health professionals can improve
diagnosis and control of hypertension and diabetes among women
of reproductive age by providing health education, particularly to
women at  risk  for  these  conditions,  including overweight  and
obese women and racial/ethnic minorities. They also can work
with women with hypertension and diabetes after diagnosis to
properly manage their conditions. Evidence-based programs such
as  the  National  Diabetes  Prevention  Program and the  Million
Hearts initiative address diabetes and hypertension; however, these
programs are geared toward an older population. Connecting wo-
men to interventions or programs that are targeted to women of re-
productive age, such as The Magnolia Project, can facilitate health
education and screening services for these women, especially wo-
men who lack access to a regular source of care (25). Future inter-
ventions should seek to overcome barriers that are specific to ra-
cial/ethnic minority groups and incorporate culturally appropriate,
respectful care and services that address the social determinants of
health (eg, transportation, housing insecurity) (26).
Our study has several limitations. Because we restricted our dia-
betes analysis to women who provided a fasting blood sample, we
had a small sample size, which resulted in wide confidence inter-
vals for some comparisons and limited our ability to detect true
differences. In addition, we combined multiple years of data to
achieve sufficient sample size for the analysis overall, limiting the
ability to disentangle the effect of trends (3–5,8) of increasing pre-
valence of these conditions among women of reproductive age.
Some covariates of interest, such as insurance status, may be tran-
sient and change over time.
An additional limitation is that we examined hypertension and dia-
betes in non-pregnant women; we did not assess history of preg-
nancy-induced hypertension or diabetes, which are associated with
development of these chronic conditions later in life. Future ana-
lyses could explore these areas. Overall, however, our analysis
provides advantages over other analyses of women of reproduct-
ive age because it used both self-reported and standardized meas-
ured data.
Our study was based on recent data and improves our understand-
ing of disparities in the prevalence, diagnosis, and control of hy-
pertension and diabetes among women of reproductive age. These
disparities  mirror  disparities  in  maternal  and infant  outcomes.
Findings from our study may facilitate opportunities to improve
awareness and control of these conditions among women of repro-
ductive age and improve the long-term health outcomes of wo-
men later in life. Adequately addressing these conditions may also
potentially improve inequities in birth outcomes.
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Tables
Table 1. Characteristics of Non-Pregnant Women Aged 20–44, NHANES 2011–2016
Characteristic Weighted Denominatora Weighted No.b %c (95% CI)
Age, y
20–34 50,018,292 29,695,171 59.4 (56.6–62.1)
35–39 9,744,417 19.5 (17.9–21.2)
40–44 10,578,705 21.2 (19.2–23.3)
Race/ethnicity
Non-Hispanic white 50,018,292 28,103,804 56.2 (51.2–61.1)
Non-Hispanic black 6,857,756 13.7 (11.0–17.0)
Hispanic 9,867,791 19.7 (16.4–23.6)
Other 5,188,941 10.4 (9.1–11.9)
Education level
<High school diploma 50,018,292 6,266,820 12.5 (10.7–14.6)
High school diploma 8,493,558 17.0 (15.1–19.1)
>High school diploma 35,226,226 70.5 (67.0–73.7)
Body mass index, kg/m2
Normal or underweight 49,906,433 18,885,653 38.2 (35.4–41.0)
Overweight 12,476,053 25.2 (23.4–27.1)
Obese 18,094,169 36.6 (34.8–38.4)
Insurance status
Publicly insured 49,906,433 9,190,888 18.6 (16.4–20.9)
Privately insured 29,057,469 58.6 (55.5–61.7)
Uninsured 11,304,289 22.8 (20.6–25.2)
Hypertension
Has hypertension 47,556,182 4,428,498 9.3 (8.1–10.7)
  Is unaware of hypertension status 4,428,498 750,284 16.9 (13.2–21.5)
  Has uncontrolled hypertension 4,428,498 1,803,248 40.7 (35.0–46.7)
Diabetes
Has diabetes 50,376,524 2,256,582 4.5 (3.4–5.9)
  Has diagnosed diabetes 50,376,524 1,606,530 3.2 (2.3–4.5)
    Has uncontrolled diabetes 1,606,530 827,973 51.5 (37.0–65.8)
  Has undiagnosed diabetes 50,376,524 650,052 1.3 (0.8–2.0)
Abbreviations: CI, confidence interval; NHANES, National Health and Nutrition Examination Survey.
a Values used for denominator in calculating percentages.
b Weighted numbers may not add up to the total denominator because of missing data or rounding.
c Percentages may not sum to 100% because of rounding.
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Table 2. Prevalence and Adjusted Prevalence Ratiosa of Hypertension, Unawareness of Hypertension, and Uncontrolled Hypertension, by Selected Characteristics of
Non-Pregnant Women Aged 20–44, NHANES, 2011–2016
Characteristic
Has Hypertension,
% (Weighted n) P b
Adjusted PR
(95% CI)
Is Unaware of
Hypertension, %
(Weighted n) P b
Adjusted PR
(95% CI)
Has Uncontrolled
Hypertension, %
(Weighted n) P b
Adjusted PR
(95% CI)
Age, y
20–34 3.6 (998,940)
<.001
1.0 [Ref] 26.0 (259,428)
.20
1.0 [Ref] 55.7 (556,662)
.06
1.0 [Ref]
35–39 15.1 (1,412,725) 3.9 (3.0–5.2) 15.9 (223,874) 0.7 (0.4–1.2) 37.7 (532,118) 0.8 (0.5–1.1)
40–44 20.0 (2,016,833) 5.1 (3.7–7.1) 13.2 (266,982) 0.5 (0.2–0.9) 35.4 (714,468) 0.7 (0.5–0.9)
Race/ethnicity
Non-Hispanic white 8.2 (2,208,478)
<.001
1.0 [Ref] 16.4 (363,102)
.17
1.0 [Ref] 29.6 (654,144)
<.001
1.0 [Ref]
Non-Hispanic black 18.7 (1,225,450) 1.7 (1.4–2.2) 14.9 (182,530) 1.0 [Ref]
(0.5–2.1)
53.6 (657,246) 1.7 (1.2–2.4)
Hispanic 7.5 (690,525) 0.8 (0.6–1.0) 14.5 (100,000) 1.0 (0.5–2.2) 44.3 (305,668) 1.3 (0.8–2.1)
Other 6.2 (304,045) 0.9 (0.7–1.4) 34.4 (104,652) 2.1 (1.0–4.3) 61.2 (186,190) 2.0 (1.3–3.0)
Education level
<High school
diploma
12.0 (705,717)
.03
1.0 [Ref] 15.5 (109,438)
.91
1.0 [Ref] 42.2 (297,802)
.93
1.0 [Ref]
High school diploma 11.3 (905,371) 1.0 (0.7–1.5) 19.0 (171,687) 1.3 (0.6–2.9) 42.8 (387,276) 1.1 (0.7–1.6)
>High school
diploma
8.4 (2,817,410) 0.8 (0.6–1.1) 16.7 (469,159) 0.9 (0.4–1.9) 39.7 (1,118,171) 1.0 (0.6–1.5)
Body mass index
Normal or
underweight
3.4 (622,142)
<.001
1.0 [Ref] 39.9 (247,918)
.10
1.0 [Ref] 60.3 (374,904)
.02
1.0 [Ref]
Overweight 6.5 (776,485) 1.7 (1.1–2.5) 10.3 (80,160) 0.3 (0.1–0.6) 23.2 (18,0069) 0.4 (0.2–0.7)
Obese 17.2 (2,981,356) 3.8 (2.8–5.3) 14.2 (422,206) 0.4 (0.2–0.8) 41.4 (1,235,550) 0.6 (0.5–0.9)
Insurance status
Privately insured 9.2 (2,552,408)
.07
1.0 [Ref] 17.4 (443,592)
.02
1.0 [Ref] 36.4 (929,885)
.003
1.0 [Ref]
Publicly insured 12.0 (1,039,649) 1.1 (0.9–1.4) 8.9 (92,319) 0.5 (0.2–0.8) 31.4 (326,534) 0.7 (0.4–1.0)
Uninsured 7.4 (797,966) 0.8 (0.5–1.3) 25.2 (200,902) 1.2 (0.7–2.2) 63.7 (508,354) 1.5 (1.1–2.1)
Abbreviations: CI, confidence interval; NHANES, National Health and Nutrition Examination Survey; PR, prevalence ratio; Ref, reference.
a Adjusted for all other variables in analysis.
b Determined by χ2 test; P < .05 considered significant.
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Table 3. Prevalence and Adjusted Prevalence Ratiosa of Diabetes, Undiagnosed Diabetes, and Uncontrolled Diabetes, by Selected Characteristics of Non-Pregnant
Women Aged 20–44, NHANES, 2011–2016
Characteristic
Has Diabetes, %
(Weighted n) P b
Adjusted PR
(95% CI)
Has Undiagnosed
Diabetes, %
(Weighted n) P b
Adjusted PR
(95% CI)
Has Uncontrolled
Diabetes, %
(Weighted n) P b
Adjusted PR
(95% CI)
Age, y
20–34 2.5  (738,995)
<.001
1.0 [Ref] 0.9 (253,807)
<.001
1.0 [Ref] 44.8 (217,548)
.76
1.0 [Ref]
35–39 6.0 (593,406) 2.2 (1.2–4.1) 1.9 (185,957) 2.0 (0.8–5.1) 61.6 (250,819) 1.9 (0.7–4.9)
40–44 8.7 (924,181) 3.1 (1.7–5.8) 2.0 (210,288) 2.2 (0.8–5.7) 50.4 (359,606) 1.8 (0.7–4.4)
Race/ethnicity
Non-Hispanic white 3.0 (860,012)
.009
1.0 [Ref] 0.4 (123,066)
<.001
1.0 [Ref] 54.0 (398,251)
.047
1.0 [Ref]
Non-Hispanic black 8.2 (562,833) 2.0 (1.1–3.5) 3.1 (211,662) 6.1
(2.0–18.6)
72.5 (254,676) 1.4 (0.9–2.2)
Hispanic 5.9 (575,823) 1.5 (0.8- 2.7) 2.0 (198,901) 3.7
(1.2–11.1)
42.5 (160,056) 0.9 (0.3–2.3)
Other 5.1 (257,914) 2.6 (1.1–6.0) 2.3 (116,424) 8.6
(2.1–35.2)
10.6 (14,990) 0.2
(0.02–1.1)
Education level
<High school
diploma
5.9 (422,084)
.48
1.0 [Ref] 2.4 (173,923)
.004
1.0 [Ref]0 30.5 (75,688)
.48
1.0 [Ref]
High school diploma 5.3 (427,406) 1.1 (0.5–2.5) 1.1 (90,602) 0.5 (0.1–2.1) 61.4 (206,618) 1.6 (0.6–4.3)
>High school
diploma
4.0 (1,407,092) 1.0 (0.5–1.9) 1.1 (385,528) 0.7 (0.3–1.7) 53.4 (545,667) 1.3 (0.5–3.5)
Body mass index
Normal or under
weight
0.6 (108,414)
<.001
1.0 [Ref] 0.3 (59,281)
<.001
1.0 [Ref] 0 (0)
.32
 —c
Overweight 3.5 (432,412) 5.5
(1.6–18.8)
0.8 (99,323) 2.2
(0.3–15.5)
63.7 (211,997)  —c
Obese 8.9 (1,688,792) 13.5
(4.4–41.5)
2.5 (478,503) 7.2
(1.7–30.2)
50.9 (615,976)  —c
Insurance status
Privately Insured 3.7 (1,041,739)
.14
1.0 [Ref] 0.9 (259,382)
.002
1.0 [Ref] 61.4 (480,365)
.47
1.0 [Ref]
Publicly Insured 5.6 (543,488) 1.2 (0.6–2.4) 1.6 (151,835) 1.0 (0.4–2.7) 40.4 (158,285) 0.5 (0.2–1.1)
Uninsured 5.6 (656,946) 1.4 (0.8–2.2) 2.0 (238,835) 1.5 (0.6–3.7) 41.8 (174,914) 0.6 (0.3–1.2)
Abbreviations: CI, confidence interval; NHANES, National Health and Nutrition Examination Survey; PR, prevalence ratio; Ref, reference.
a Adjusted for all other variables in analysis.
b Determined by χ2 test; P < .05 considered significant.
c Body mass index not used as a covariate in the model for uncontrolled diabetes because of insufficient sample size.
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